Company Information

Company AstraZeneca México
www.astrazeneca.mx
Type:
Company
Country:
Mexico
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
08 July 2021
Letter of Commitment
Next Communication on Progress (COP) due on:
30 June 2024

Parent Company

Country Company Name
United Kingdom AstraZeneca UK Ltd

Communication On Progress

Published On Title Level
2022-06-02 Communication on Progress AstraZeneca 2021 Advanced

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.

Parent Communication On Progress

Published On Title Level
2022-07-18 2022 Communication on Progress Not applicable
2022-06-27 Communication on Progress Advanced
2021-03-31 Communication on Progress 2020 Advanced
2020-04-03 Communication on Progress Advanced
2019-04-04 Communication on Progress AstraZeneca 2019 Advanced
2018-04-23 Communication on Progress Advanced
2017-04-29 Communication on Progress Active
2016-06-06 Communication on Progress AstraZeneca 2016 Active
2015-06-10 AstraZeneca Communication on Progress 2015 Learner
2015-03-06 Grace Letter Not applicable
2014-03-28 Communication on Progress 2014 Advanced
2013-03-28 AstraZeneca 2012 Advanced
2012-03-28 2011 Communication on Progress Advanced
2011-04-08 2010 Communication on Progress Advanced
2010-12-21 Grace Letter Not applicable